Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Sep;93(9):1071-6.
doi: 10.1136/hrt.2005.077909. Epub 2006 Dec 28.

Circulating endothelial progenitor cells in patients with cardiac syndrome X

Haim Shmilovich  1 , Varda Deutsch, Arie Roth, Hylton Miller, Gad Keren, Jacob George
Affiliations

Circulating endothelial progenitor cells in patients with cardiac syndrome X

Haim Shmilovich et al. Heart. 2007 Sep.

Abstract

Background: Cardiac syndrome X (CSX) encompasses the constellation of anginal chest pain in the presence of a pathological functional test and a normal coronary angiogram. Endothelial progenitor cells (EPCs) in the peripheral circulation contribute to tissue vascularisation.

Objective: To investigate the number and functional properties of circulating EPCs in patients with CSX.

Methods: 17 patients with CSX and a referent population (n = 20) were matched for age, atherosclerotic risk factors and use of drugs. Numbers of EPCs were studied by FACS, and their functional properties, including their proliferative capacity, adherence to matrix and mature endothelial cells as well as their ability to support in vitro tube formation, were investigated. Levels of soluble markers that associate with peripheral mobilisation and homing were studied in the serum samples of all subjects.

Results: Patients with CSX had significantly increased numbers of circulating EPCs as compared with the referent population (both CD34+/KDR and CD34+/CD133+). The proliferative capacity of EPCs and their ability to support in vitro tube formation were significantly impaired in patients with CSX as compared with the referent population. However, adhesiveness of EPCs from patients with CSX to fibronectin and cultured mature endothelial cells was enhanced as compared with the referent population. Serum vascular endothelial growth factor correlated with peripheral CD34+/KDR cell numbers, whereas serum concentration of erythropoietin correlated with the number of circulating CD34+/CD133+ cells

Conclusion: Patients with CSX have a significantly altered circulating EPC phenotype that could potentially aid in understanding the complex pathogenesis of the syndrome.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kaski J C, Aldama G, Cosin‐Sales J. Cardiac syndrome X. Diagnosis, pathogenesis and management. Am J Cardiovasc Drugs 20044179–194. - PubMed
    1. Kaski J C. Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Circulation 2004109568–572. - PubMed
    1. Panting J R, Gatehouse P D, Yang G Z.et al Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular resonance imaging. N Engl J Med 20023461948–1953. - PubMed
    1. Chen J W, Hsu N W, Wu T C.et al Long‐term angiotensin‐converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Am J Cardiol 200290974–982. - PubMed
    1. Piatti P, Fragasso G, Monti L D.et al Acute intravenous L‐arginine infusion decreases endothelin‐1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels. Circulation 2003107429–436. - PubMed

MeSH terms